Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6

Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S17. doi: 10.1186/bcr2436. Epub 2009 Dec 18.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast / drug effects
  • Breast / pathology
  • Breast / surgery
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery*
  • Diphosphonates / administration & dosage
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Letrozole
  • Mass Screening
  • Mastectomy / methods
  • Mastectomy / statistics & numerical data*
  • Nitriles / administration & dosage
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Tamoxifen / administration & dosage
  • Treatment Outcome
  • Triazoles / administration & dosage
  • Zoledronic Acid

Substances

  • Antineoplastic Agents, Hormonal
  • Diphosphonates
  • Imidazoles
  • Nitriles
  • Triazoles
  • Tamoxifen
  • Zoledronic Acid
  • Letrozole